[1] Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes care 2011;34:1481-1486.
https://doi.org/ 10.2337/dc10-2415.
[2] Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet 2017;389:2239-2251.
https://doi.org/10.1016/S0140-6736(17)30058-2.
[3] Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obesity (2005) 2010; 34:791-799.
https://doi.org/10.1038/ijo.2010.5.
[4] Gurevich KG, Poston WS, Anders B, Ivkina MA, Archangelskaya A, Jitnarin N, Starodubov VI. Obesity prevalence and accuracy of BMI-defined obesity in Russian firefighters. Occup Med-Oxford 2017; 67:61-63.
https://doi.org/10.1093/occmed/kqw136.
[5] Han SJ, Boyko EJ. The Evidence for an Obesity Paradox in Type 2 Diabetes Mellitus. Diabetes Metab J 2018;42:179-187.
https://doi.org/10.4093/dmj.2018.0055.
[6] Malone JI, Hansen BC. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes 2019;20:5-9.
https://doi.org/10.1111/pedi.12787.
[7] Thomas G, Khunti K, Curcin V, Molokhia M, Millett C, Majeed A, Paul S. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes Metab 2014;16:317-325.
https://doi.org/10.1111/dom.12217.
[8] Eckel N, Mühlenbruch K, Meidtner K,et al. Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes. Metabolism 2015;64:862-871.
https://doi.org/10.1016/j.metabol.2015.03.009.
[9] Wang B, Zhang M, Wang S, Wang C, Wang J, Li L, Zhang L, Ren Y, Han C, Zhao Y et al. Dynamic status of metabolically healthy overweight/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus: A cohort study of a rural adult Chinese population. Obes Res Clin Pr 2018;12:61-71.
https://doi.org/10.1016/j.orcp.2017.10.005.
[10] Taylor R, Holman RR. Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clin Sci 2015;128:405-410.
https://doi.org/10.1042/CS20140553.
[11] Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Obes Res Clin Pr 2010;89:309-319.
https://doi.org/10.1016/j.diabres.2010.04.012.
[12] Claessen H, Brenner H, Drath C, Arndt V. Repeated measures of body mass index and risk of health related outcomes. Eur J Epidemiol 2012;27:215-224.
https://doi.org/10.1007/s10654-012-9669-7.
[13] Siren R, Eriksson JG, Vanhanen H. Waist circumference a good indicator of future risk for type 2 diabetes and cardiovascular disease. BMC public health 2012;12:631.
https://doi.org/10.1186/1471-2458-12-631.
[14] Elizalde-Barrera CI, Rubio-Guerra AF, Lozano-Nuevo JJ, Olvera-Gomez JL. Triglycerides and waist to height ratio are more accurate than visceral adiposity and body adiposity index to predict impaired fasting glucose. Diabetes Res Clin Pr 2019;153:49-54.
https://doi.org/10.1016/j.diabres.2019.05.019.
[15] Ahn N, Baumeister SE, Amann U, Rathmann W, Peters A, Huth C, Thorand B, Meisinger C. Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes. Sci Rep-UK 2019;9:9693.
https://doi.org/10.1038/s41598-019-46187-8.
[16] Dong L, Lin M, Wang W, Ma D, Chen Y, Su W, Chen Z, Wang S, Li X, Li Z et al. Lipid accumulation product (LAP) was independently associatedwith obstructive sleep apnea in patients with type 2 diabetes mellitus. BMC Endocr Disord 2020;20:179.
https://doi.org/10.1186/s12902-020-00661-x.
[17] Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PloS One 2019;14:e0212963.
https://doi.org/10.1371/journal.pone.0212963.
[18] Kavaric N, Klisic A, Ninic A. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus? J Clin Lab Anal 2018;32.
https://doi.org/10.1002/jcla.22283.
[19] Janghorbani M, Almasi SZ, Amini M. The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction. Acta Diabetol 2015;52:781-788.
https://doi.org/10.1007/s00592-014-0709-5.
[20] Moreno G, Mangione CM. Management of cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: 2002-2012 literature review. J Am Geriatr Soc 2013;61:2027-2037.
https://doi.org/10.1111/jgs.12513.
[21] Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002;15:83-96.
[22] Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D, Zhu D, Chen L, Chen L, Guo L et al. Standards of care for type 2 diabetes in China. Diabetes-Metab Res 2016;32:442-458.
https://doi.org/10.1002/dmrr.2827.
[23] Hsieh SD, Yoshinaga H, Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 2003;27:610-616.
https://doi.org/10.1038/sj.ijo.0802259.
[24] Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes care 2010;33:920-922.
https://doi.org/10.2337/dc09-1825.
[25] Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disor 2005;5:26.
https://doi.org/10.1186/1471-2261-5-26.
[26] Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat D 2008;6:299-304.
https://doi.org/10.1089/met.2008.0034.
[27] WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
https://doi.org/10.1016/S0140-6736(03)15268-3.
[28] Hsieh SD, Yoshinaga H. Do people with similar waist circumference share similar health risks irrespective of height? Tohoku J Exp Med 1999;188:55-60.
https://doi.org/10.1620/tjem.188.55.
[29] Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis Obes Rev 2012;13:275-286.
https://doi.org/10.1111/j.1467-789X.2011.00952.x.
[30] Song P, Li X, Bu Y, Ding S, Zhai D, Wang E, Yu Z. Temporal trends in normal weight central obesity and its associations with cardiometabolic risk among Chinese adults. Sci Rep-UK 2019;9:5411.
https://doi.org/10.1038/s41598-019-41986-5.
[31] Yang J, Wang F, Wang J, Han X, Hu H, Yu C, Yuan J, Yao P, Miao X, Wei S et al. Using different anthropometric indices to assess prediction ability of type 2 diabetes in elderly population: a 5 year prospective study. BMC Geriatr 2018;18:218.
https://doi.org/10.1186/s12877-018-0912-2.
[32] Dong H, Xu Y, Zhang X, Tian S. Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes. Sci Rep-UK 2017;7:8822.
https://doi.org/10.1038/s41598-017-09455-z.
[33] Wei J, Liu X, Xue H, Wang Y, Shi Z. Comparisons of Visceral Adiposity Index, Body Shape Index, Body Mass Index and Waist Circumference and Their Associations with Diabetes Mellitus in Adults. Nutrients 2019;11.
https://doi.org/10.3390/nu11071580.
[34] Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis 2011;10:88.
https://doi.org/10.1186/1476-511X-10-88.
[35] Wakabayashi I, Daimon T. A strong association between lipid accumulation product and diabetes mellitus in japanese women and men. J Atheroscler Thromb 2014; 21:282-288.
https://doi.org/10.5551/jat.20628.
[36] Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 2010;9:45.
https://doi.org/10.1186/1476-511X-9-45.
[37] Nusrianto R, Ayundini G, Kristanti M, Astrella C, Amalina N, Muhadi, Riyadina W, Tahapary DL, Soewondo P. Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: The Bogor cohort study of non-communicable diseases risk factors. Diabetes Res Clin Pr 2019;155:107798.
https://doi.org/10.1016/j.diabres.2019.107798.
[38] Wang T, Lu J, Shi L, Chen G, Xu M, Xu Y, Su Q, Mu Y, Chen L, Hu R et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endo 2020;8:115-124.
https://doi.org/10.1016/S2213-8587(19)30425-5.
[39] Lee SH, Han K, Yang HK, Kim HS, Cho JH, Kwon HS, Park YM, Cha BY, Yoon KH. A novel criterion for identifying metabolically obese but normal weight individuals using the product of triglycerides and glucose. Nutr Diabetes 2015;5:e149.
https://doi.org/10.1186/s12933-017-0514-x.
[40] Zhang M, Wang B, Liu Y, Sun X, Luo X, Wang C, Li L, Zhang L, Ren Y, Zhao Y et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study. Cardiovasc Diabetol 2017;16:30.
https://doi.org/10.1186/s12933-017-0514-x.
[41] Dikaiakou E, Vlachopapadopoulou EA, Paschou SA, Athanasouli F, Panagiotopoulos L, Kafetzi M, Fotinou A, Michalacos S. Triglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents. Endocrine 2020;70:58-64.
https://doi.org/10.1007/s12020-020-02374-6.
[42] Fritz J, Bjørge T, Nagel G, Manjer J, Engeland A, Häggström C, Concin H, Teleka S, Tretli S, Gylling B, Lang A, Stattin P, Stocks T, Ulmer H. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. Int J Epidemiol 2020;49:193-204.
https://doi.org/10.1093/ije/dyz053.
[43] Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pr 2011;93:e98-e100.
https://doi.org/10.1016/j.diabres.2011.05.030.
[44] Perry RJ, Camporez JG, Kursawe R, Titchenell PM, Zhang D, Perry CJ, Jurczak MJ, Abudukadier A, Han MS, Zhang XM et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 2015;160:745-758.
https://doi.org/10.1016/j.cell.2015.01.012.
[45] Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 2016;126:12-22.
https://doi.org/10.1172/JCI77812.
[46] Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995;44:863-870.
https://doi.org/10.2337/diab.44.8.863.
[47] Low S, Khoo KCJ, Irwan B, Sum CF, Subramaniam T, Lim SC, Wong TKM. The role of triglyceride glucose index in development of Type 2 diabetes mellitus. Diabetes Res Clin Pr 2018; 143:43-49.
https://doi.org/10.1016/j.diabres.2018.06.006.
[48] Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes care 2013;36:1047-1055.
https://doi.org/10.2337/dc12-1805.
[49] González ND, Íñigo SL, Delgado JP, Montero FA, Martinez JA. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort. Prev Med 2016;86:99-105.
https://doi.org/10.1016/j.ypmed.2016.01.022.
[50] Lee JW, Lim NK, Park HY. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans. BMC Endocr Disord 2018;18:33.
https://doi.org/10.1186/s12902-018-0259-x.
[51] Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. PloS One 2016;11:e0149731.
https://doi.org/10.1371/journal.pone.0149731.
[52] Zheng S, Shi S, Ren X, Han T, Li Y, Chen Y, Liu W, Hou PC, Hu Y. Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients. cross-sectional and prospective cohort study. J Trans Med 2016;14:260.
https://doi.org/10.1186/s12967-016-1020-8.